Cover Image

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Lee, Kyong Ju, Ji, Yuan
Format:	Preprint
Published:	2025
Subjects:	Applications Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)

The Backfill i3+3 Design for Dose-Finding Trials in Oncology
by: Liu, Jiaxin, et al.
Published: (2023)

Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation
by: Amevor, Robert, et al.
Published: (2026)

Bayesian Design and Analysis of Precision Trials with Partial Borrowing
by: Golchi, Shirin, et al.
Published: (2026)

The Modified Combo i3+3 Design for Novel-Novel Combination Dose-Finding Trials in Oncology
by: Liu, Jiaxin, et al.
Published: (2024)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
by: Qiu, Sky, et al.
Published: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)

Precision Mental Health: Predicting Heterogeneous Treatment Effects for Depression through Data Integration
by: Brantner, Carly L., et al.
Published: (2025)

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data
by: Qiu, Sky, et al.
Published: (2025)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)

Statistical Design of Pragmatic Trials Using Electronic Health Record Data when Outcome Assessments are Uncontrolled and Irregular
by: Bobb, Jennifer F., et al.
Published: (2026)

Two-stage Adaptive Design Cluster Randomised Trials
by: Watson, Samuel I., et al.
Published: (2026)

CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
by: Zhang, Fanni, et al.
Published: (2025)

Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
by: Yamada, Kana, et al.
Published: (2026)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
by: Silva, Rebecca B., et al.
Published: (2025)

On Assessing Overall Survival (OS) in Oncology Studies
by: Hsu, Jason C.
Published: (2025)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
by: Yang, Peng, et al.
Published: (2026)

Latent Theme Dictionary Model for Finding Co-occurrent Patterns in Process Data
by: Fang, Guanhua, et al.
Published: (2019)

Bayesian Spatial Point Process Modeling for Cluster Randomized Trials
by: Lee, Jooyeon, et al.
Published: (2025)

Cumulative Logit Ordinal Regression with Proportional Odds under Nonignorable Missing Response -- Application to Phase III Trial
by: Maity, Arnab Kumar, et al.
Published: (2025)

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
by: Gao, Yujing, et al.
Published: (2025)

Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
by: Ballerini, Veronica, et al.
Published: (2023)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)

Implementing Response-Adaptive Randomisation in Stratified Rare-disease Trials: Design Challenges and Practical Solutions
by: Das, Rajenki, et al.
Published: (2024)

Adaptive Selection of the Optimal Strategy to Improve Precision and Power in Randomized Trials
by: Balzer, Laura B., et al.
Published: (2022)

Improving the Estimation of Site-Specific Effects and their Distribution in Multisite Trials
by: Lee, JoonHo, et al.
Published: (2023)

Automatic Quality Control for Agricultural Field Trials -- Detection of Nonstationarity in Grid-indexed Data
by: Wolf, Karen, et al.
Published: (2025)

Nonparametric Bayesian Multi-Treatment Mixture Cure Survival Model with Application in Pediatric Oncology
by: Chang, Peter, et al.
Published: (2025)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
by: Mao, Guangcai, et al.
Published: (2025)

Distribution-Free Selection of Low-Risk Oncology Patients for Survival Beyond a Time Horizon
by: Sesia, Matteo, et al.
Published: (2025)

Pharmacometrics-Enabled DOse OPtimization (PEDOOP) for Seamless Phase I-II Trials in Oncology
by: Yuan, Shijie, et al.
Published: (2023)

Feasible Dose-Response Curves for Continuous Treatments Under Positivity Violations
by: Bao, Han, et al.
Published: (2025)